Adolescents’ genetic risks tied to psychotic symptoms

Researchers examine the relationships between neuropsychiatric and cognitive polygenic scores, attention-related phenotypes, and psychosis symptoms.

SCOTUS raises questions over legal standing in abortion pill case

WASHINGTON, DC – Supreme Court justices appeared uncertain on Tuesday that doctors and anti-abortion groups have standing to challenge the FDA’s current label for the

March 27, 2024

Expanded methadone access: giving patients greater choice

WASHINGTON — Nicholas Voyles, executive director of the Indiana Recovery Alliance, ended up missing his daily dose of methadone on Monday. He’d requested “guest dosing”

April 30, 2024

FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz) – Biotech Investments

Formycon AG / Key word(s): Regulatory Approval FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz) 27-Sep-2024 / 21:56 CET/CEST Disclosure of an inside information acc.

September 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.